RK

Roopraj Kapoorchand Jain

Director DIN 06764842
DIN 06764842 First appointment Feb 2014
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Roopraj Kapoorchand Jain

Data last updated:

Roopraj Kapoorchand Jain was a Director at Stulan Techno Private Limited (from 2018) and Director at Stuvet Pharmaceuticals Private Limited (from 2014).

DIN 06764842
First Appointment 03 Feb 2014
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Stulan Techno Private Limited U72900PN2018PTC179624
Director16 Oct 20182018Strike Off
Director03 Feb 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Stulan Techno Private Limited
Stuvet Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Roopraj Kapoorchand Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Roopraj Kapoorchand Jain

Roopraj Kapoorchand Jain was first appointed on 03 Feb 2014 as Director at Stuvet Pharmaceuticals Private Limited. The most recent appointment on record is 16 Oct 2018 at Stulan Techno Private Limited.

Roopraj Kapoorchand Jain held 2 earlier board appointments: Stulan Techno Private Limited (Director, from 16 Oct 2018); Stuvet Pharmaceuticals Private Limited (Director, from 03 Feb 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available